Alignment Healthcare, Inc.

NasdaqGS:ALHC Stock Report

Market Cap: US$967.6m

Alignment Healthcare Future Growth

Future criteria checks 1/6

Alignment Healthcare is forecast to grow earnings and revenue by 37.3% and 17.2% per annum respectively. EPS is expected to grow by 38.2% per annum. Return on equity is forecast to be -87.8% in 3 years.

Key information

37.3%

Earnings growth rate

38.2%

EPS growth rate

Healthcare earnings growth15.8%
Revenue growth rate17.2%
Future return on equity-87.8%
Analyst coverage

Good

Last updated11 Apr 2024

Recent future growth updates

Recent updates

It's A Story Of Risk Vs Reward With Alignment Healthcare, Inc. (NASDAQ:ALHC)

Feb 24
It's A Story Of Risk Vs Reward With Alignment Healthcare, Inc. (NASDAQ:ALHC)

Does Alignment Healthcare (NASDAQ:ALHC) Have A Healthy Balance Sheet?

Jan 18
Does Alignment Healthcare (NASDAQ:ALHC) Have A Healthy Balance Sheet?

Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Subdued P/S Might Signal An Opportunity

Nov 08
Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Subdued P/S Might Signal An Opportunity

Alignment Healthcare: Investors Should Align Themselves With Insiders

Oct 05

Alignment Healthcare announces 9M shares secondary offering

Sep 15

Alignment Healthcare completes debt refinancing

Sep 06

Alignment Healthcare: This Next-Generation Medicare Startup Is Fully Valued

Aug 22

Alignment Health Plan plans to expand into three Nevada counties

Jul 20

Alignment Healthcare Grows Revenue But Operating Losses Remain

May 17

Earnings Release: Here's Why Analysts Cut Their Alignment Healthcare, Inc. (NASDAQ:ALHC) Price Target To US$15.75

Mar 06
Earnings Release: Here's Why Analysts Cut Their Alignment Healthcare, Inc. (NASDAQ:ALHC) Price Target To US$15.75

Earnings and Revenue Growth Forecasts

NasdaqGS:ALHC - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,376-76-16N/A5
12/31/20252,881-96-14-510
12/31/20242,402-113-40-2210
12/31/20231,824-148-95-59N/A
9/30/20231,720-158-53-21N/A
6/30/20231,624-1634978N/A
3/31/20231,528-1462551N/A
12/31/20221,434-150-69-45N/A
9/30/20221,371-1405374N/A
6/30/20221,304-146-38-19N/A
3/31/20221,246-179-73-52N/A
12/31/20211,168-195-99-79N/A
9/30/20211,112-180-80-59N/A
6/30/20211,066-123-66-46N/A
3/31/20211,002-70-26-9N/A
12/31/2020959-23-88N/A
12/31/2019757-45-19N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ALHC is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ALHC is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ALHC is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ALHC's revenue (17.2% per year) is forecast to grow faster than the US market (8.1% per year).

High Growth Revenue: ALHC's revenue (17.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ALHC is forecast to be unprofitable in 3 years.


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.